Gale Pharma (India) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 17-07-2024
- Paid Up Capital ₹ 0.50 M
as on 17-07-2024
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2020
- Revenue -66.90%
(FY 2020)
- Profit -46.37%
(FY 2020)
- Ebitda -51.31%
(FY 2020)
- Net Worth -29.81%
(FY 2020)
- Total Assets -9.50%
(FY 2020)
About Gale Pharma (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Chilukuri Krishna, Tipparam Nageshwari, and Praveen Kottacheruvu serve as directors at the Company.
- CIN/LLPIN
U51909TG2013PTC087583
- Company No.
087583
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 May 2013
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gale Pharma (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chilukuri Krishna  | Managing Director | 18-Feb-2016 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tipparam Nageshwari | Director | 10-May-2013 | Current |
| Praveen Kottacheruvu | Director | 26-Jun-2015 | Current |
Financial Performance of Gale Pharma (India).
Gale Pharma (India) Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 66.9% decrease. The company also saw a substantial fall in profitability, with a 46.37% decrease in profit. The company's net worth observed a substantial decline by a decrease of 29.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gale Pharma (India)?
In 2020, Gale Pharma (India) had a promoter holding of 40.00% and a public holding of 60.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sahaja Herbals (India) Private LimitedActive 11 years 7 monthsTipparam Nageshwari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gale Pharma (India)?
Unlock and access historical data on people associated with Gale Pharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gale Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gale Pharma (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
